Extending Omalizumab Treatment Intervals in Patients with Chronic Spontaneous Urticaria
Phase 4
Recruiting
- Conditions
- Chronic Spontaneous UrticariaChronic Urticaria, Idiopathic
- Interventions
- First Posted Date
- 2023-06-23
- Last Posted Date
- 2024-10-16
- Lead Sponsor
- Simon Francis Thomsen
- Target Recruit Count
- 40
- Registration Number
- NCT05916937
- Locations
- 🇩🇰
Department of Dermatology, Bispebjerg Hospital, Copenhagen, Copenhagen N, Denmark
© Copyright 2025. All Rights Reserved by MedPath